PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) FOR NEWLY DIAGNOSED GLIOBLASTOMA

被引：0

作者：

Ahluwalia, Manmeet ^{[1
]}

Reardon, David ^{[2
]}

Abad, Ajay ^{[3
]}

Curry, William ^{[4
]}

Wong, Eric ^{[5
]}

Peereboom, David ^{[1
]}

Belal, Ahmed ^{[3
]}

Qiu, Jingxin ^{[3
]}

Mogensen, Kathleen ^{[3
]}

Schilero, Cathy ^{[1
]}

Casucci, Danielle ^{[3
]}

Mechtler, Laszlo ^{[3
]}

Uhlmann, Erik ^{[3
]}

Ciesielski, Michael ^{[3
]}

Fenstermaker, Robert ^{[3
]}

机构：

[1] Cleveland Clin, Cleveland, OH 44106 USA

[2] Dana Farber Canc Inst, Boston, MA 02115 USA

[3] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

[4] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA

[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

来源：

NEURO-ONCOLOGY | 2018年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ATIM-41

引用

页码：10 / 11

页数：2

共 50 条

[21] Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial [J].

Grossman, Stuart A. ;

Ye, Xiaobu ;

Chamberlain, Marc ;

Mikkelsen, Tom ;

Batchelor, Tracy ;

Desideri, Serena ;

Piantadosi, Steven ;

Fisher, Joy ;

Fine, Howard A. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) :4155-4161

[22] Anti-telomerase vaccine in patients with newly diagnosed, unmethylated MGMT glioblastoma: A phase II study [J].

Carpentier, Antoine F. ;

Verlut, Clotilde ;

Ghiringhelli, Francois ;

Bronnimann, Charlotte ;

Ursu, Renata ;

Fumet, Jean David ;

Gherga, Elisabeta ;

Lefort, Felix ;

Belin, Catherine ;

Vernerey, Dewi ;

Hervieu, Alice ;

Laheurte, Caroline ;

Meurisse, Aurelia ;

Jacquin, Marion ;

Malfroy, Marine ;

Fagnoni-Legat, Christine ;

Lehmann-Che, Jacqueline ;

Boullerot, Laura ;

Cuzzubbo, Stefania ;

Adotevi, Olivier .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)

[23] Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma [J].

Phuphanich, Surasak ;

Wheeler, Christopher J. ;

Rudnick, Jeremy D. ;

Mazer, Mia ;

Wang, HongQian ;

Nuno, Miriam A. ;

Richardson, Jaime E. ;

Fan, Xuemo ;

Ji, Jianfei ;

Chu, Ray M. ;

Bender, James G. ;

Hawkins, Elma S. ;

Patil, Chirag G. ;

Black, Keith L. ;

Yu, John S. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (01) :125-135

[24] Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma [J].

Surasak Phuphanich ;

Christopher J. Wheeler ;

Jeremy D. Rudnick ;

Mia Mazer ;

HongQian Wang ;

Miriam A. Nuño ;

Jaime E. Richardson ;

Xuemo Fan ;

Jianfei Ji ;

Ray M. Chu ;

James G. Bender ;

Elma S. Hawkins ;

Chirag G. Patil ;

Keith L. Black ;

John S. Yu .

Cancer Immunology, Immunotherapy, 2013, 62 :125-135

[25] Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial [J].

Roth, Patrick ;

Gorlia, Thierry ;

Reijneveld, Jaap C. ;

de Vos, Filip ;

Idbaih, Ahmed ;

Frenel, Jean-Sebastien ;

Le Rhun, Emilie ;

Sepulveda, Juan Manuel ;

Perry, James ;

Masucci, G. Laura ;

Freres, Pierre ;

Hirte, Hal ;

Seidel, Clemens ;

Walenkamp, Annemiek ;

Lukacova, Slavka ;

Meijnders, Paul ;

Blais, Andre ;

Ducray, Francois ;

Verschaeve, Vincent ;

Nicholas, Garth ;

Balana, Carmen ;

Bota, Daniela A. ;

Preusser, Matthias ;

Nuyens, Sarah ;

Dhermain, Frederic ;

van den Bent, Martin ;

O'Callaghan, Chris J. ;

Vanlancker, Maureen ;

Mason, Warren ;

Weller, Michael .

NEURO-ONCOLOGY, 2024, 26 (09) :1670-1682

[26] Phase II trial of bevacizumab and temozolomide for upfront treatment of elderly patients with newly diagnosed glioblastoma. [J].

Nghiemphu, Phioanh Leia ;

Bahng, Hye Hyun ;

Lai, Albert ;

Faiq, Nadia ;

Yong, William H. ;

Green, Richard M. ;

Polikoff, Jonathan ;

Spier, Cynthia Elizabeth ;

Iwamoto, Fabio Massaiti ;

Lassman, Andrew B. ;

Cloughesy, Timothy Francis .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

[27] Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial [J].

Perez-Larraya, Jaime Gallego ;

Ducray, Francois ;

Chinot, Olivier ;

Catry-Thomas, Isabelle ;

Taillandier, Luc ;

Guillamo, Jean-Sebastien ;

Campello, Chantal ;

Monjour, Annick ;

Cartalat-Carel, Stephanie ;

Barrie, Maryline ;

Huchet, Aymeri ;

Beauchesne, Patrick ;

Matta, Mona ;

Mokhtari, Karima ;

Tanguy, Marie-Laure ;

Honnorat, Jerome ;

Delattre, Jean-Yves .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (22) :3050-3055

[28] Challenges in the development of a survivin vaccine ( SurVaxM) for malignant glioma [J].

Fenstermaker, Robert A. ;

Ciesielski, Michael J. .

EXPERT REVIEW OF VACCINES, 2014, 13 (03) :377-385

[29] Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma -: A phase II study [J].

Weller, M ;

Streffer, J ;

Wick, W ;

Kortmann, RD ;

Heiss, E ;

Küker, W ;

Meyermann, R ;

Dichgans, J ;

Bamberg, M .

CANCER, 2001, 91 (02) :423-427

[30] Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma [J].

Wen, PY ;

Gigas, DC ;

MacDonald, L ;

Batchelor, TT ;

Schiff, D ;

Xu, R ;

Ramakrishna, N ;

Weaver, S ;

Kracher, J ;

Bradshaw, J ;

Levy, B ;

Bailey, E ;

Kesari, S ;

Maher, EA ;

Henson, J ;

Black, PM .

NEURO-ONCOLOGY, 2004, 6 (04) :385-385

← 1 2 3 4 5 →